Prices of 390 anti-cancer drugs slashed by up to 87 per cent: Check full list here
The National Pharmaceutical Pricing Authority today issued a list of 390 anti-cancer drugs which will be available at a cheaper rate for patients.
The prices of the listed drugs have been cut by up to 87 per cent by the pharmaceutical body.
Related Stories
Prices of at least 38 medicines like Bendamustine, Bortezomib and Pemetrexed have been cut down by 75 per cent and more.
390 out of 426 anti-cancer drugs (91%) show price reduction through Trade Margin rationalisation.
It is estimated that the savings due to a reduction in prices would be approximately Rs 800 crore.